Science
Mechanism of Action
Works by modulating the skin's endocannabinoid system to suppress inflammatory cytokine production, particularly IL-1α, while optimizing the IL-1RA to IL-1α ratio for reduced sensitivity and enhanced barrier function
Research
Clinical Evidence
High confidence1%
Key findings
- 01 Double-blind controlled study at 1.0% demonstrated significant reduction in erythema, improved hydration metrics, and balanced inflammatory markers
- 02 Combination study at 0.5% with Palmitamide MEA showed enhanced barrier repair and pruritus reduction in atopic-prone subjects
Transparency
Dusting Analysis
Effective concentrations begin at 0.5%, making sub-0.1% concentrations likely ineffective for therapeutic benefits
The Formula
Formulation
Stability
Maintains integrity within physiological pH ranges but susceptible to hydrolysis above pH 9
Synergies
- Palmitamide MEA
- ceramides
- cholesterol
Conflicts
- strong oxidizing agents
- highly alkaline conditions
Safety
Safety Profile
EU-approved cosmetic ingredient with established safety profile at standard usage concentrations
Your Skin
Skin Compatibility
Our Assessment
Verdict
A clinically-validated endocannabinoid modulator that delivers measurable anti-inflammatory and barrier-repair benefits for compromised skin.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources